BioNTech SE Shares Outstanding 2019-2024 | BNTX

BioNTech SE shares outstanding for the quarter ending September 30, 2024 were 0.245B, a 2.03% increase year-over-year.

  • BioNTech SE 2023 shares outstanding were 0.243B, a 2.84% decline from 2022.
  • BioNTech SE 2022 shares outstanding were 0.25B, a 3.81% decline from 2021.
  • BioNTech SE 2021 shares outstanding were 0.26B, a 4.5% increase from 2020.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

BioNTech SE Shares Outstanding 2019-2024 | BNTX

  • BioNTech SE 2023 shares outstanding were 0.243B, a 2.84% decline from 2022.
  • BioNTech SE 2022 shares outstanding were 0.25B, a 3.81% decline from 2021.
  • BioNTech SE 2021 shares outstanding were 0.26B, a 4.5% increase from 2020.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$150.5B
Bristol Myers Squibb (BMY)$118.1B
Vertex Pharmaceuticals (VRTX)$115.4B
Gilead Sciences (GILD)$109.4B
CSL (CSLLY)$85.4B
Regeneron Pharmaceuticals (REGN)$81.8B
GSK (GSK)$69.3B
Argenex SE (ARGX)$34.4B
Alnylam Pharmaceuticals (ALNY)$30.2B
Biogen (BIIB)$22.6B
Illumina (ILMN)$21.4B
BeiGene (BGNE)$18.3B
Moderna (MRNA)$14.3B
Incyte (INCY)$13.6B
Genmab (GMAB)$13.6B
Insmed (INSM)$13.2B
BioMarin Pharmaceutical (BMRN)$11.8B
Vaxcyte (PCVX)$10.9B
Bio-Techne Corp (TECH)$10.5B
Sarepta Therapeutics (SRPT)$10.2B
Exact Sciences (EXAS)$10B
Exelixis (EXEL)$9.8B
Revolution Medicines (RVMD)$9.5B
Bio-Rad Laboratories (BIO.B)$9.4B
QIAGEN (QGEN)$9.3B
Intra-Cellular Therapies (ITCI)$8.8B
Roivant Sciences (ROIV)$8.4B
Ascendis Pharma (ASND)$7.5B
Repligen (RGEN)$7.2B
Legend Biotech (LEGN)$7B